Pharmacokinetics and Bioequivalence Study of Budesonide Inhalation Aerosol in Humans
Status:
COMPLETED
Trial end date:
2025-01-20
Target enrollment:
Participant gender:
Summary
The test formulation of Budesonide Inhalation Aerosol is bioequivalent to the reference formulation in healthy Chinese subjects under fasting conditions.